康缘药业：2025年半年度净利润约1.42亿元

Group 1 - The company, Kangyuan Pharmaceutical, reported a revenue of approximately 1.642 billion yuan for the first half of 2025, representing a year-on-year decrease of 27.29% [1] - The net profit attributable to shareholders of the listed company was about 142 million yuan, down 40.12% year-on-year [1] - The basic earnings per share were 0.25 yuan, reflecting a decrease of 39.02% compared to the previous year [1]